Available:*
Library | Item Barcode | Call Number | Material Type | Item Category 1 | Status |
---|---|---|---|---|---|
Searching... | 30000010042318 | TX551 P49 2003 | Open Access Book | Book | Searching... |
Searching... | 30000010057982 | TX551 P49 2003 | Open Access Book | Book | Searching... |
On Order
Summary
Summary
Plant foods are rich in micronutrients, but they also contain an immense variety of biologically-active, non-nutritive compounds that contribute to colour, flavour and other characteristics. These phytochemicals have been increasingly linked to reducing the risk of chronic diseases such as cancer, osteoporosis and coronary heart disease. Edited by two leading experts in the field, and with a distinguished international team of contributors, Phytochemical functional foods assesses the evidence for their health benefits and reviews the key issues involved in successful product development.
Part one reviews research on the health benefits of phytochemicals, including chapters on cardiovascular disease, cancer, bone and gastrointestinal health, as well as the functional benefits of particular groups of phytochemicals such as phytoestogens, carotenoids and flavonoids. Part two considers the important safety and quality issues in developing phytochemical products. There are chapters on establishing appropriate intake levels, testing the safety of phytochemicals and establishing health claims through clinical trials. Part two also covers such issues as extracting and enhancing phytochemical compounds for use in food products.
Phytochemical functional foods will establish itself as a standard reference on one of the most important sectors in the functional foods market.
Author Notes
Professor Ian Johnson works at the UK Institute of Food Research
Professor Gary Williamson is Head of Metabolic and Genetic Regulation at the Nestle Research Centre in Switzerland
Table of Contents
List of contributors | p. xi |
1 Introduction | p. 1 |
Part I The health benefits of phytochemicals | p. 3 |
2 Nutritional phenolics and cardiovascular disease | p. 5 |
2.1 Introduction | p. 5 |
2.2 LDL oxidation and atherogenesis | p. 6 |
2.3 Polyphenols and cell response | p. 7 |
2.4 Polyphenols and activated NF-[kappa]B | p. 8 |
2.5 Other aspects of polyphenols as modulators of signal transduction | p. 9 |
2.6 Indirect evidence for polyphenol activity in atherogenesis | p. 12 |
2.7 Conclusion and future trends | p. 13 |
2.8 List of abbreviations | p. 14 |
2.9 References | p. 14 |
3 Phytochemicals and cancer: an overview | p. 18 |
3.1 Introduction | p. 18 |
3.2 What is cancer? | p. 20 |
3.3 The nature of tumour growth | p. 22 |
3.4 Models of carcinogenesis | p. 24 |
3.5 Diet and gene interactions | p. 25 |
3.6 Cancer risk and particular nutrients | p. 27 |
3.7 Phytochemicals | p. 32 |
3.8 Carotenoids | p. 33 |
3.9 Flavonoids | p. 35 |
3.10 Phytoestrogens | p. 36 |
3.11 Glucosinolates | p. 37 |
3.12 Other nutritional factors | p. 38 |
3.13 Conclusion and future trends | p. 38 |
3.14 References | p. 39 |
4 Food-borne glucosinolates and cancer | p. 45 |
4.1 Introduction | p. 45 |
4.2 Sources, structures and metabolites of the glucosinolates | p. 46 |
4.3 Digestion and absorption | p. 48 |
4.4 Glucosinolate breakdown products and cancer | p. 51 |
4.5 Blocking the initiation phase | p. 52 |
4.6 Suppressing the promotion phase | p. 55 |
4.7 Summary and conclusions | p. 57 |
4.8 Acknowledgements | p. 58 |
4.9 Sources of further information and advice | p. 58 |
4.10 References | p. 59 |
5 Phytoestrogens and health | p. 65 |
5.1 Introduction | p. 65 |
5.2 Mechanisms of phytoestrogen action: receptor and non-receptor mediated | p. 66 |
5.3 Other effects of phytoestrogens | p. 69 |
5.4 The health effects of phytoestrogens: osteoporosis, cardiovascular disease and thyroid function | p. 71 |
5.5 The health effects of phytoestrogens: central nervous system and immune function | p. 73 |
5.6 The health effects of phytoestrogens: cancer | p. 74 |
5.7 The health effects of phytoestrogens: fertility, development and hormonal effects | p. 77 |
5.8 Future trends and priorities for research | p. 79 |
5.9 Sources of further information and advice | p. 80 |
5.10 References | p. 80 |
6 Phytoestrogens and bone health | p. 88 |
6.1 Introduction | p. 88 |
6.2 Composition and metabolism of phytoestrogens | p. 89 |
6.3 Human studies on soy isoflavones and bone maintenance | p. 90 |
6.4 Animal studies on soy isoflavones and bone maintenance | p. 94 |
6.5 Mechanisms of action of isoflavones in bone health | p. 96 |
6.6 Dietary recommendations | p. 100 |
6.7 Conclusion and future trends | p. 100 |
6.8 References | p. 101 |
7 Carotenoids in food: bioavailability and functional benefits | p. 107 |
7.1 Introduction: the concept of bioavailability | p. 107 |
7.2 Functional benefits of carotenoids: vision, cancer and cardiovascular disease | p. 109 |
7.3 Factors affecting carotenoid bioavailability: food sources and intakes | p. 112 |
7.4 Release from food structures: maximising availability for absorption | p. 114 |
7.5 Absorption and metabolism | p. 118 |
7.6 Methods for predicting absorption | p. 119 |
7.7 Tissue concentrations | p. 121 |
7.8 Future trends | p. 123 |
7.9 Sources of further information and advice | p. 124 |
7.10 References | p. 124 |
8 The functional benefits of flavonoids: the case of tea | p. 128 |
8.1 Introduction: types of tea | p. 128 |
8.2 Flavonoids and other components of tea | p. 129 |
8.3 Functional benefits | p. 134 |
8.4 Mechanisms of anticarcinogenic and other activity | p. 138 |
8.5 Potential side-effects of tea constituents | p. 141 |
8.6 Tea drinking and flavonoid intake | p. 141 |
8.7 Tea extracts and their applications | p. 143 |
8.8 Analytical methods for detecting flavonoids | p. 145 |
8.9 Future trends | p. 148 |
8.10 Sources of further information and advice | p. 149 |
8.11 References | p. 150 |
9 Phytochemicals and gastrointestinal health | p. 160 |
9.1 Introduction | p. 160 |
9.2 The gastrointestinal tract | p. 161 |
9.3 The influence of phytochemicals on gastrointestinal function | p. 162 |
9.4 Phytochemicals and digestion | p. 163 |
9.5 Phytochemicals, waste and toxin elimination and other functions | p. 168 |
9.6 Phytochemicals, gastrointestinal bacteria and gut health | p. 172 |
9.7 Future trends | p. 174 |
9.8 References | p. 175 |
Part II Developing phytochemical functional products | p. 187 |
10 Assessing the intake of phytoestrogens: isoflavones | p. 189 |
10.1 Introduction | p. 189 |
10.2 Assessing the dietary intake of isoflavones | p. 189 |
10.3 Factors affecting phytoestrogen absorption and metabolism | p. 193 |
10.4 Isoflavone intake and health | p. 196 |
10.5 Establishing appropriate intake levels for isoflavones | p. 206 |
10.6 Future trends | p. 209 |
10.7 Sources of further information and advice | p. 210 |
10.8 References | p. 211 |
11 Testing the safety of phytochemicals | p. 222 |
11.1 Introduction: the health benefits of phytochemicals | p. 222 |
11.2 Evaluating the safety of phytochemicals in food | p. 224 |
11.3 Risk evaluation of food chemicals | p. 225 |
11.4 Potential food carcinogens | p. 227 |
11.5 Problems in assessing safety: the example of [beta]-carotene | p. 229 |
11.6 Improving risk assessment of phytochemicals | p. 231 |
11.7 Future trends | p. 233 |
11.8 Sources of further information and advice | p. 236 |
11.9 References | p. 236 |
12 Investigating the health benefits of phytochemicals: the use of clinical trials | p. 238 |
12.1 Introduction | p. 238 |
12.2 Types of clinical trials | p. 239 |
12.3 Hypothesis testing, endpoints and trial design | p. 240 |
12.4 Assessing sample size | p. 242 |
12.5 Other issues in making trials effective | p. 244 |
12.6 Ethical issues | p. 248 |
12.7 Sources of further information and advice | p. 249 |
12.8 References and bibliography | p. 250 |
13 The genetic enhancement of phytochemicals: the case of carotenoids | p. 253 |
13.1 Introduction | p. 253 |
13.2 Carotenoids in plants: structure | p. 254 |
13.3 Carotenoids in plants: distribution | p. 255 |
13.4 The functional benefits of carotenoids | p. 257 |
13.5 Carotenoid biosynthesis and encoding genes | p. 259 |
13.6 Strategies and methods for transformation to enhance carotenoids | p. 266 |
13.7 Examples of genetically modified crops with altered carotenoid levels | p. 270 |
13.8 Future trends | p. 272 |
13.9 Sources of further information | p. 273 |
13.10 Acknowledgements | p. 273 |
13.11 References | p. 273 |
14 Developing phytochemical products: a case study | p. 280 |
14.1 Introduction | p. 280 |
14.2 Chemical enhancement of phytochemicals: the case of phloem | p. 282 |
14.3 Heating and extraction of phenolic compounds | p. 283 |
14.4 Measuring phenolic compounds | p. 286 |
14.5 The functional benefits of phloem | p. 287 |
14.6 Testing functional benefits | p. 288 |
14.7 Future trends | p. 293 |
14.8 Sources of further information and advice | p. 294 |
14.9 References | p. 294 |
15 The impact of food processing in phytochemicals: the case of antioxidants | p. 298 |
15.1 Introduction: natural antioxidants present in foods | p. 298 |
15.2 Changes in antioxidants: mechanism of action | p. 298 |
15.3 Changes during heating: water as the heat transfer | p. 300 |
15.4 Changes during heating: air as the heat transfer medium | p. 302 |
15.5 Changes during heating: where energy is transferred in waves | p. 304 |
15.6 Changes during heating: oil as the heat transfer medium | p. 305 |
15.7 Changes in antioxidants during non-thermal processes | p. 307 |
15.8 Changes in antioxidants during storage | p. 308 |
15.9 Future trends | p. 310 |
15.10 Sources of further information and advice | p. 311 |
15.11 References | p. 312 |
16 Optimising the use of phenolic compounds in foods | p. 315 |
16.1 Introduction | p. 315 |
16.2 Analysing antioxidant activity in food | p. 320 |
16.3 Antioxidant interaction in food models | p. 330 |
16.4 Polyphenols in processed food | p. 333 |
16.5 Bioavailability of plant phenols | p. 337 |
16.6 Future trends | p. 338 |
16.7 Sources of further information and advice | p. 340 |
16.8 Acknowledgement | p. 340 |
16.9 References | p. 340 |
17 Phytochemical products: rice bran | p. 347 |
17.1 Introduction | p. 347 |
17.2 Phytonutrients in rice bran | p. 349 |
17.3 Phytonutrients with particular health benefits | p. 353 |
17.4 Functional benefits: cancer | p. 363 |
17.5 Functional benefits: cardiovascular disease and diabetes | p. 366 |
17.6 Functional benefits: immune function | p. 368 |
17.7 Functional benefits: liver, gastrointestinal and colonic health | p. 369 |
17.8 Conclusions | p. 370 |
17.9 Acknowledgements | p. 370 |
17.10 References | p. 371 |
Index | p. 377 |